Home
Conditions
BRCA2 Gene Mutation

Clinical trial condition

BRCA2 Gene Mutation

Explore clinical trials studying BRCA2 Gene Mutation. Study availability and eligibility vary by location and protocol.

14 public trials 1 recruiting study

Refine in advanced search Browse all conditions

BRCA2 Gene Mutation trial results

Recruiting

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

NCT04294927

Conditions: Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +18 more
Locations: UChicago Medicine Chicago, Illinois, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

Washington University Medical Center St Louis, Missouri, United States

View all 66 locations

View Trial Details

Completed

Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations

NCT05264532

Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer

NCT01009788

Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation, Breast Cancer, +7 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT03552471

Conditions: Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +24 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation

NCT02953457

Conditions: Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +20 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

The Feinstein Institute for Medical Research/Lennox Hill Hospital New York, United States

View Trial Details

Completed

Prospective Research of Outcomes After Salpingo-oophorectomy

NCT01948609

Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

NCT03377556

Conditions: ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation, +18 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 1157 locations

View Trial Details

Completed

A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

NCT02197000

Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation, Breast Diseases, +5 more
Locations: Rabin Medical Center, Beilinson Hospital Petah Tikva, Israel

View Trial Details

Completed

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

NCT01975363

Conditions: Adenocarcinoma, Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, +16 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes

NCT02286687

Conditions: ATM Gene Mutation, Advanced Malignant Neoplasm, BRCA1 Gene Mutation, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

BRCA2 Gene Mutation

BRCA2 Gene Mutation trial results

Related conditions